Healthcare Transition Support for Young Adults With Congenital Adrenal Hyperplasia
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study helps young people with congenital adrenal hyperplasia (a condition affecting hormone production) move smoothly from pediatric to adult care. Researchers will develop and test a transition program with patients, caregivers, and healthcare providers to make this shift easier and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with congenital adrenal hyperplasia (CAH), any type or severity level
- You are at least 16 years old
- You are currently being treated at a pediatric endocrinology clinic (hormone specialist clinic for children)
- You speak English and can complete questionnaires (with help if needed)
- You are able to attend study visits during the study period
- You can understand and consent to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication for children with classic congenital adrenal hyperplasia (CAH). It aims to see if the drug helps better control hormone levels and reduce the need for high doses of current steroid medicines.
This trial is creating a registry to track adult males with congenital adrenal hyperplasia (CAH) from 21-hydroxylase deficiency. It helps doctors learn more about the condition and how it changes over time.
This study tests a new drug, atumelnant, for adults with classic congenital adrenal hyperplasia (CAH) caused by 21-OHD. It aims to see if it can help control hormone levels while allowing lower doses of current steroid medications.
This early study tests Lu AG13909 in people with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. It aims to see how the drug affects hormone levels and whether it is safe for different CAH hormone patterns.
This study tests a new medicine called crinecerfont in children under 4 years old with classic congenital adrenal hyperplasia (CAH), a condition where the body doesn't make certain hormones properly. Researchers want to learn if the medicine is safe and how it works in the body.
This study tests a program to help young adults with rare hormone or gland conditions move from pediatric to adult medical care. If you are 18 or older and being treated at a pediatric endocrinology clinic, this program may help make your care smoother.
Hear when a new Congenital Adrenal Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.